The march of pluripotent stem cells in cardiovascular regenerative medicine

Area of Science:

• Cardiovascular research
• Regenerative medicine
• Stem cell biology

Background:

• Cardiovascular disease (CVD) is a leading global cause of death, with heart failure as a major component.
• Myocardial loss significantly drives heart failure progression, necessitating novel therapeutic strategies.
• Stem cell therapy (SCT) offers a promising approach to mitigate cardiac degeneration and improve heart function.

Purpose of the Study:

• To review various stem cell types, focusing on induced pluripotent stem cells (iPSCs).
• To critically discuss methods for somatic cell reprogramming into iPSCs and iPSCs into cardiomyocytes (CMs).
• To highlight the potential of iPSC-derived CMs in cardiac regeneration and disease modeling.

Main Methods:

• Discussion of embryonic and adult stem cells.
• Detailed analysis of induced pluripotent stem cell (iPSC) properties.
• Critical evaluation of reprogramming techniques (integrating and non-integrating) and iPSC-derived cardiomyocyte (iPSC-CM) differentiation protocols.

Main Results:

• iPSCs offer a versatile platform for generating cardiomyocytes.
• Various methods exist for iPSC reprogramming and differentiation, each with distinct advantages and limitations.
• Characterization of iPSCs and iPSC-CMs is crucial for therapeutic applications.

Conclusions:

• Stem cell therapy, particularly using iPSC-derived cardiomyocytes, holds significant potential for myocardial regeneration.
• iPSC-CMs are valuable tools for disease modeling, aiding in understanding cardiovascular pathologies.
• Further research into iPSC technology can advance therapeutic strategies for heart failure and cardiac repair.